Dysregulation of GPCR Signaling in Cardiovascular Diseases: A Potential Role for Exercise Training?
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
PURPOSE: The superfamily of G protein-coupled receptors (GPCR) are activated by biological molecules (e.g. neurotransmitters) and are involved in many physiological events. As exaggerated GPCR-mediated signaling may contribute to cardiovascular disorders, RGS proteins (regulators of G-protein signaling) are viewed as an important regulatory molecule for the negative modulation of this signaling pathway. To address the significance of RGS proteins and suggest potential effects of exercise training on this molecule, a literature review on RGS proteins was conducted. METHODS: A systemic search in PUBMED was performed to obtain previous studies investigating roles of RGS proteins in the cardiovascular systems. RESULTS: RGS proteins directly bind to the Gα subunit of heterotrimeric G proteins to inhibit GPCR signaling pathways and terminate their activity. Using mice genetically lacking RGS2 and RGS5, these proteins have been shown to contribute to pressure overloadinduced cardiac remodeling. Further, it has been suggested that systemic knockout of RGS2 protein causes hypertension by potentiating G protein signaling-mediated vascular responses and impairing nitric oxide/cGMP-induced vasorelaxation. Thus, RGS proteins have been suggested as potential drug targets for cardiovascular disorders accompanied by dysregulation of RGS proteins and GPCR signaling. Although exercise training has also been well-documented to strengthen cardiovascular function and ameliorate circulatory diseases, cellular mechanisms underlying the contribution of exercise intervention to RGS-mediated GPCR signaling have not been explored. CONCLUSIONS: This brief review discusses roles played by RGS proteins in the cardiovascular system and suggests future studies for investigating the interaction between exercise training and RGS protein-mediated regulation of GPCR signaling.
Abstract
PURPOSE: The superfamily of G protein-coupled receptors (GPCR) are activated by biological molecules (e.g. neurotransmitters) and are involved in many physiological events. As exaggerated GPCR-mediated signaling may contribute to cardiovascular disorders, RGS proteins (regulators of G-protein signaling) are viewed as an important regulatory molecule for the negative modulation of this signaling pathway. To address the significance of RGS proteins and suggest potential effects of exercise training on this molecule, a literature review on RGS proteins was conducted. METHODS: A systemic search in PUBMED was performed to obtain previous studies investigating roles of RGS proteins in the cardiovascular systems. RESULTS: RGS proteins directly bind to the Gα subunit of heterotrimeric G proteins to inhibit GPCR signaling pathways and terminate their activity. Using mice genetically lacking RGS2 and RGS5, these proteins have been shown to contribute to pressure overloadinduced cardiac remodeling. Further, it has been suggested that systemic knockout of RGS2 protein causes hypertension by potentiating G protein signaling-mediated vascular responses and impairing nitric oxide/cGMP-induced vasorelaxation. Thus, RGS proteins have been suggested as potential drug targets for cardiovascular disorders accompanied by dysregulation of RGS proteins and GPCR signaling. Although exercise training has also been well-documented to strengthen cardiovascular function and ameliorate circulatory diseases, cellular mechanisms underlying the contribution of exercise intervention to RGS-mediated GPCR signaling have not been explored. CONCLUSIONS: This brief review discusses roles played by RGS proteins in the cardiovascular system and suggests future studies for investigating the interaction between exercise training and RGS protein-mediated regulation of GPCR signaling.
참고문헌 (66)
- Brady AE, "G protein-coupled receptor interacting proteins : emerging roles in localization and signal transduction", Cellular Signalling, 14(4), pp.297~309 (2002)
- Salon JA, "The significance of G proteincoupled receptor crystallography for drug discovery", Pharmacological Reviews, 63(4), pp.901~937 (2011)
- Schoneberg T, "Mutant G-protein-coupled receptors as a cause of human diseases", Pharmacology & Therapeutics, 104(3), pp.173~206 (2004)
- Hendriks-Balk MC, "Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins", European Journal of Pharmacology, 585(2-3), pp.278~291 (2008)
- Insel PA, "Impact of GPCRs in clinical medicine : monogenic diseases, genetic variants and drug targets", Biochimica Biophysica Acta, 1768(4), pp.994~1005 (2007)
- Rosskopf D, "Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicine", Pharmacological Reviews, 60(4), pp.513~535 (2008)
- Brinks HL, "Regulation of GPCR signaling in hypertension", Biochimica Biophysica Acta, 1802(12), pp.1268~1275 (2010)
- Holobotovskyy V, "Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling", Circulation Research, 112(5), pp.781~791 (2013)
- Hollinger S, "Cellular regulation of RGS proteins : modulators and integrators of G protein signaling", Pharmacological Reviews, 54(3), pp.527~559 (2002)
- Ross EM, "GTPase-activating proteins for heterotrimeric G proteins : regulators of G protein signaling(RGS)and RGS-like proteins", Annual Review of Biochemistry, 69, pp.795~827 (2000)
- Gu S, "RGS proteins : identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function", Clinical Science(London), 116(5), pp.391~399 (2009)
- Abramow-Newerly M, "RGS proteins have a signalling complex : interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins", Cellular Signalling, 18(5), pp.579~591 (2006)
- Bansal G, "R4 RGS proteins : regulation of G-protein signaling and beyond", Pharmacology & Therapeutics, 116(3), pp.473~495 (2007)
- Ganss R, "Keeping the Balance Right : Regulator of G Protein Signaling 5 in Vascular Physiology and Pathology", Progress Molecular Biology and Translational Science, 133, pp.93~121 (2015)
- Bernstein LS, "RGS4 binds to membranes through an amphipathic alpha-helix", The Journal of Biological Chemistry, 275(24), pp.18520~18526 (2000)
- Chen C, "The membrane association domain of RGS16 contains unique amphipathic features that are conserved in RGS4 and RGS5", The Journal of Biological Chemistry, 274(28), pp.19799~19806 (1999)
- Neitzel KL, "Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signaling", Seminars in Cell & Developmental Biology, 17(3), pp.383~389 (2006)
- Cho H, "The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling", Biochemical Journal, 371(Pt 3), pp.973~980 (2003)
- Xu X, "RGS proteins determine signaling specificity of Gq-coupled receptors", The Journal of Biological Chemistry, 274(6), pp.3549~3556 (1999)
- Adebiyi A, "RGS2 regulates urotensin II-induced intracellular Ca2+ elevation and contraction in glomerular mesangial cells", Journal of Cellular Physiology, 229(4), pp.502~511 (2014)
- Wang Q, "Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells", The Journal of Biological Chemistry, 277(28), pp.24949~24958 (2002)
- Hoffmann M, "Differential capacities of the RGS1, RGS16 and RGS-GAIP regulators of G protein signaling to enhance alpha2A-adrenoreceptor agonist-stimulated GTPase activity of G(o1)alpha", Journal of Neurochemistry, 78(4), pp.797~806 (2001)
- Itoh M, "Alternative splicing of RGS8gene changes the binding property to the M1 muscarinic receptor to confer receptor type-specific Gq regulation", Journal of Neurochemistry, 99(6), pp.1505~1516 (2006)
- Bansal G, "RGS13 controls g protein-coupled receptor-evoked responses of human mast cells", The Journal of Immunology, 181(11), pp.7882~7890 (2008)
- Iwai K, "RGS18acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1", NFAT signaling pathway, 2007, pp.22(10), 1612~1620
- von Buchholtz L, "RGS21 is a novel regulator of G protein signalling selectively expressed in subpopulations of taste bud cells", European Journal of Neuroscience, 19(6), pp.1535~1544 (2004)
- Zeng W, "The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling", The Journal of Biological Chemistry, 273(52), pp.34687~34690 (1998)
- Zhou J, "Characterization of RGS5 in regulation of G protein-coupled receptor signaling", Life Sciences, 68(13), pp.1457~1469 (2001)
- Matsuzaki N, "Potent and selective inhibition of angiotensin AT1 receptor signaling by RGS2 : roles of its N-terminal domain", Cellular Signalling, 23(6), pp.1041~1049 (2011)
- Sjogren B, "Thinking outside of the"RGS box" : new approaches to therapeutic targeting of regulators of G protein signaling", Molecular Pharmacology, 78(4), pp.550~557 (2010)
- da Costa Goncalves AC, "Spinophilin regulates central angiotensin II-mediated effect on blood pressure", Journal of Molecular Medicine(Berlin), 89(12), pp.1219~1229 (2011)
- da Costa-Goncalves AC, "Role of the multidomain protein spinophilin in blood pressure and cardiac function regulation", Hypertension, 52(4), pp.702~707 (2008)
- Wang X, "Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2and the third intracellular loop of G-protein-coupled receptors", Nature Cell Biology, 7(4), pp.405~411 (2005)
- Takimoto E, "Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice", Journal of Clinical Investigation, 119(2), pp.408~420 (2009)
- Heximer SP, "Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice", Journal of Clinical Investigation, 111(4), pp.445~452 (2003)
- Tang KM, "Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure", Nature Medicine, 9(12), pp.1506~1512 (2003)
- Tokudome T, "Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart", Circulation, 117(18), pp.2329~2339 (2008)
- Wang X, "RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy", Journal of Molecular and Cellular Cardiology, 44(3), pp.539~550 (2008)
- Zhang S, "RGS3and RGS4 are GTPase activating proteins in the heart", Journal of Molecular and Cellular Cardiology, 30(2), pp.269~276 (1998)
- Mittmann C, "Expression of ten RGS proteins in human myocardium : functional characterization of an upregulation of RGS4 in heart failure", Cardiovascular Research, 55(4), pp.778~786 (2002)
- Owen VJ, "Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure", European Heart Journal, 22(12), pp.1015~1020 (2001)
- Tamirisa P, "RGS4 inhibits G-protein signaling in cardiomyocytes", Circulation, 99(3), pp.441~447 (1999)
- Adams LD, "A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media", Circulation Research, 87(7), pp.623~631 (2000)
- Li J, "Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque", Journal of Vascular Surgery, 40(3), pp.519~528 (2004)
- Liu SL, "The effect of statin on the aortic gene expression profiling", Internation Journal of Cardiology, 114(1), pp.71~77 (2007)
- Kirsch T, "Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats", Brain Research, 910(1-2), pp.106~115 (2001)
- Bondjers C, "Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells", American Journal of Pathology, 162(3), pp.721~729 (2003)
- Cho H, "Pericyte-specific expression of Rgs5 : implications for PDGF and EDG receptor signaling during vascular maturation", The FASEB Journal, 17(3), pp.440~442 (2003)
- Li H, "Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload", Proceedings of the National Academy of Sciences USA, 107(31), pp.13818~13823 (2010)
- Holobotovskyy V, "Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia", Science Translational Medicine, 7(290), pp.290ra88~ (2015)
- Yang Z, "Regulator of G-protein signaling-5 inhibits bronchial smooth muscle contraction in severe asthma", American Journal of Respiratory Cell and Molecular Biology, 46(6), pp.823~832 (2012)
- Rogers JH, "RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload", Journal of Clinical Investigation, 104(5), pp.567~576 (1999)
- Rogers JH, "RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice", Journal of Molecular and Cellular Cardiology, 33(2), pp.209~218 (2001)
- Practice ACoO, "ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists", International Journal of Gynaecology & Obstetrics, 77(1), pp.67~75 (2002)
- Steegers EA, "Pre-eclampsia", Lancet, 376(9741), pp.631~644 (2010)
- Kvehaugen AS, "Single nucleotide polymorphisms in G protein signaling pathway genes in preeclampsia", Hypertension, 61(3), pp.655~661 (2013)
- Semplicini A, "Reduced expression of regulator of G-protein signaling 2(RGS2)in hypertensive patients increases calcium mobilization and ERK1", 2 phosphorylation induced by angiotensin II, 2006, pp.24(6), 1115~1124
- Kvehaugen AS, "Hypertension after preeclampsia and relation to the C1114G polymorphism(rs4606)in RGS2 : data from the Norwegian HUNT2study", BMC Medical Genetics, 15, pp.28~ (2014)
- Seibold A, "Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway", Molecular Pharmacology, 58(5), pp.1162~1173 (2000)
- Woodall BP, "Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy", The Journal of Biological Chemistry, 291(42), pp.21913~21924 (2016)
- de Lucia C, "Adrenal adrenoceptors in heart failure", Frontiers in Physiology, 5, pp.246~ (2014)
- Ryan JJ, "The right ventricle in pulmonary arterial hypertension : disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure", Circulation Research, 115(1), pp.176~188 (2014)
- Santulli G, "G-protein-coupled receptor kinase 2 and hypertension : molecular insights and pathophysiological mechanisms", High Blood Pressure & Cardiovascular Prevention, 20(1), pp.5~12 (2013)
- Xing W, "Improvement of vascular insulin sensitivity by downregulation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive rats", American Journal of Physiology Heart and Circulatory Physiology, 305(8), pp.H1111~H1119 (2013)
- Tuomi JM, "Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse", American Journal of Physiology Heart and Circulatory Physiology, 298(2), pp.H554~H561 (2010)
- Grillet N, "Generation and characterization of Rgs4 mutant mice", Molecular and Cellular Biology, 25(10), pp.4221~4228 (2005)
